期刊文献+

阿维A联合重组人白介素一2对预防尖锐湿疣复发的效果 被引量:1

loma acuminatuRecurrence efficacy of acitretin combined with interieukin-2 to the prevention for condy-loma acuminatum
暂未订购
导出
摘要 目的观察阿维A联合重组人白介素~2治疗尖锐湿疣(cA)及预防复发的效果。方法将入选患者随机分为对照组和治疗组;均用微波将皮损彻底清除,对照组25例不加用其他治疗,治疗组34例彻底清除皮损后应用重组人白介素一2注射液20万单位肌注,隔日1次,连用7次,并加用阿维A胶囊20mg/d,8周后改为10mg/d,维持4周。两组均随访6个月。结果治疗组复发率为11.76%,明显低于对照组的56.00%,差异具有显著性(P〈0.05)。结论阿维A联合重组人白介素一2肌注对CA具有较好的治疗作用,并能降低其复发率。 Objective To observe the efficacy and recurrence of oral acitretin combined with interleukin- 2 in patients with condyloma acuminatum (CA). Methods 59 patients with CA were randomly divided into two groups. 34 cases as observation group were treated with aeiwefin(20 mg/d orally for 8 weeks, and then the 10 mg/d for 4 weeks) and interleukin-2(2OO,lX}O unit in% qed for 7 times)after tbe warts had been eliminated by mien)wave. In the control group, 25 eases received the trealment of elimination of the warts by microwave alone. A review was given to all patients for 6 months, comparing the re]apse rate between the two groups. Resets In the observation group,recurrence rate was seen only in 4 cases(11.76%)while in the control group, there were 14 cases of recurrence(56.00% ). The relapse rate of the investigation group was significantly lower than that of the control group. The difference was statistically significant in the two groups (P〈 0.05). Conelusima Using aeitrefin combined with interleukin-2 in the ~.atment for CA can lower the re]apes rate.
出处 《国际医药卫生导报》 2011年第18期2295-2296,共2页 International Medicine and Health Guidance News
关键词 阿维A 重组人白介素一2 尖锐湿疣 Acitretin Interleukin-2 Condyloma acuminatum
  • 相关文献

参考文献3

二级参考文献22

  • 1Zouboulis CC.Retinoids--which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol,2001,14: 303-315.
  • 2Cather J, Menter A. Novel therapies for psoriasis. Am J Clin Dermatol, 2002, 3:159-173.
  • 3Jackson CG.Immunomodulating drugs in the management of psoriatic arthritis. Am J Clin Dermatol, 2001, 2: 367-375.
  • 4Nyirady J, Grossman RM, Nighland M, et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatolog Treat, 2001, 12: 149157.
  • 5Wysowski DK, Swann J, Vega A. Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.J Am Acad Dermatol,2002,46:505-509.
  • 6Suchin KR, Cucchiara AJ, Gottleib SL, et al. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol, 2002, 138: 1054-1060.
  • 7Allison DS, El-Azhary RA, Calobrisi SD,et al. Pityriasis rubra pilaris in children. J Am Acad Dermatol, 2002, 47: 386-389.
  • 8Li YH, Gao XH, He CD, et al. Detection of human papillomavirus and response to oral arotinoid ethylester in 2 cases of Darier disease. Arch Dematol, 2002, 138:695-696.
  • 9Baran R. Pyogenic granuloma-like lesions associated with topical retinoid therapy.J Am Acad Dermatol, 2002, 47: 970.
  • 10Onder M, Oztas MO, Oztas P. Isotretinoininduced nail fragility and onycholysis. J Dermatology Treat, 2001, 12:115-116.

共引文献52

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部